Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$5,753,245
+$3,628,586 QoQ
Shares Held
22,863
+134.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.05%
of 13F equity value
Holder Rank
#1,231
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARMONY ASSET MANAGEMENT LLC holds $23,235,360 across 7 Drug Manufacturers - General names. ABBV ranks #2 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,641 | $11,563,705 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
22,863 | $5,753,245 | |
| 3 | AMGN |
Amgen Inc
|
6,712 | $2,430,549 | |
| 4 | JNJ |
Johnson & Johnson
|
8,341 | $2,118,363 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,524 | $571,562 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,252 | $417,882 | |
| 7 | PFE |
Pfizer Inc
|
15,783 | $380,054 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,753,245 | 22,863 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,124,659 | 9,769 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,231,661 | 9,767 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,299,655 | 9,932 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,843,392 | 9,931 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,109,237 | 10,067 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,859,630 | 10,465 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $2,140,683 | 10,840 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,875,742 | 10,936 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,187,660 | 17,505 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,364,243 | 21,709 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||